Vaccines

08 Aug 2016 Pfenex Announces Positive Anthrax Vaccine Study Results
08 Aug 2016 Latest Data From Phase 1 Trial of ProscaVax for Prostate Cancer Reinforces Safety and Benefit of Novel Cancer Vaccine
04 Aug 2016 Inovio will Independently Develop Hepatitis B Immunotherapy
02 Aug 2016 Vaxart Initiates Clinical Development of First Oral Norovirus Vaccine
01 Aug 2016 The results of phase I clinical trial of the Araclon Biotech Alzheimer's vaccine support its continuation
30 Jul 2016 Neon Therapeutics Announces FDA Acceptance of Investigational New Drug Application for Cancer Vaccine NEO-PV-01
28 Jul 2016 All rights to ALK’s SLIT-tablets in North America to revert to ALK from MSD
27 Jul 2016 GeoVax Reports Progress With Hemorrhagic Fever Vaccine Program
27 Jul 2016 FluGen Initiates a Phase 1 Clinical Trial of the RedeeFlu™ Universal Influenza Vaccine in Healthy Subjects
27 Jul 2016 Prokarium Receives £2M In Government Contracts to Develop New Vaccines Against Emerging Diseases and Bioterrorist Threats
27 Jul 2016 ARTES and Burnet Institute Join Forces to Develop Novel Hepatitis C Vaccine
26 Jul 2016 Inovio Pharmaceuticals Doses First Subject in Zika Vaccine Clinical Trial
26 Jul 2016 Valneva Announces Successful Completion of Phase II for Clostridium Difficile Vaccine Candidate
25 Jul 2016 Merck Receives Breakthrough Therapy Designation from FDA and PRIME Status from EMA for Investigational Ebola Zaire Vaccine (V920)
21 Jul 2016 Transgene to Continue Phase 1/1b Study with TG1050 in Chronic Hepatitis B Patients on the Recommendation of the Trial’s Safety Review Committee
20 Jul 2016 Hookipa Biotech Initiates First-in-Human Study of Cytomegalovirus Vaccine
19 Jul 2016 VBI Vaccines Applies its eVLP Platform in the Development of a Novel Vaccine Candidate to Prevent Zika Virus
13 Jul 2016 Pfizer Receives FDA Approval for Prevnar 13® in Adults Age 18 Through 49
12 Jul 2016 New worldwide, exclusive license agreement provides broad access to Institut Pasteur's virus vector technology – Zika vaccine development progressing with high priority
12 Jul 2016 VAXIMM initiates Phase 1 translational study in glioblastoma with oral T-cell immunotherapy, VXM01
07 Jul 2016 Valneva Announces Successful Generation of a Highly-purified Zika Vaccine Candidate Using its FDA-EMA Approved Japanese Encephalitis Platform
07 Jul 2016 Immunovaccine Announces Positive Interim Phase 1 Data for DepoVax(TM)-Based Respiratory Syncytial Virus Vaccine Candidate
01 Jul 2016 First-In-Human Study of Immbio's Novel Pneumococcal Vaccine Pnubiovax Shows Vaccine to Be Safe and Immunogenic
30 Jun 2016 GeoVax Announces Filing of Investigational New Drug Application for HIV Human Clinical Trial
29 Jun 2016 Galena Biopharma Discontinues NeuVax™ (nelipepimut-S) Phase 3, PRESENT Interim Analysis based on Independent Data Monitoring Committee Recommendation

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top